Altuglu Imre, Soyler Ilknur, Ozacar Tijen, Erensoy Selda
Department of Microbiology and Clinical Microbiology, Ege University Medical Faculty, Bornova, Izmir, Turkey.
Int J Infect Dis. 2008 May;12(3):239-44. doi: 10.1016/j.ijid.2007.07.003. Epub 2007 Oct 17.
The primary aim of this study was to determine the recent distribution of various genotypes of hepatitis C virus (HCV) in patients with chronic HCV infection in Western Turkey. Additional objectives were to determine whether there are any associations of genotype with gender and age, and to determine the nucleotide similarities and risk factors of non-1 HCV genotypes.
Serum samples from 345 patients (176 male, 169 female; mean age 53.3+/-12.7 years, range 10-81 years) with chronic HCV infection were analyzed in this study. Viral genotypes were determined by a restriction fragment length polymorphism (RFLP)-based in-house assay. To confirm genotypes for the samples with band patterns other than genotype 1, the 5' UTR was amplified and sequenced.
Genotype 1 was observed in 335 of the 345 patients (97.1%). Of these, 34 patients showed infection with subtype 1a (9.9%) and 301 with subtype 1b (87.2%). Genotypes 2, 3, and 4 were determined in 0.9%, 1.4%, and 0.6% of the patients, respectively. Patients infected with type 1 were significantly older than patients infected with non-1 genotypes; however no significant differences were recorded in gender distribution.
Genotypes other than genotype 1 are quite rare; these are possibly acquired in other countries. Turkish patients with chronic hepatitis C still represent a rather homogenous group with genotypic diversity encountered rarely.
本研究的主要目的是确定土耳其西部慢性丙型肝炎病毒(HCV)感染患者中各种HCV基因型的近期分布情况。其他目的是确定基因型与性别和年龄之间是否存在关联,以及确定非1型HCV基因型的核苷酸相似性和危险因素。
本研究分析了345例慢性HCV感染患者(176例男性,169例女性;平均年龄53.3±12.7岁,范围10 - 81岁)的血清样本。通过基于限制性片段长度多态性(RFLP)的内部检测方法确定病毒基因型。对于基因型不是1型且条带模式不同的样本,扩增并测序其5'UTR以确认基因型。
345例患者中有335例(97.1%)检测出基因型1。其中,34例患者显示为1a亚型感染(9.9%),301例为1b亚型感染(87.2%)。基因型2、3和4分别在0.9%、1.4%和0.6%的患者中检测到。感染1型的患者明显比感染非1型基因型的患者年龄大;然而,在性别分布上未记录到显著差异。
除基因型1以外的其他基因型非常罕见;这些可能是在其他国家感染的。土耳其慢性丙型肝炎患者仍然是一个相当同质化的群体,很少遇到基因型多样性的情况。